Compare ResMed Inc. (RMD) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs United States Oil ETF — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.89B), while United States Oil ETF trades at $149.83. The key difference: ResMed Inc. pays a 1.19% dividend while United States Oil ETF pays none, and United States Oil ETF is trading nearer its 52-week high, ResMed Inc. nearer its low. Which is the better fit depends on your goals.
| RMD | USO | |
|---|---|---|
Market Cap | $31.89B | — |
Sector | Health | — |
52-Week High | $283.28 | $152.96 |
52-Week Low | $182.82 | $66.17 |
Enterprise Value | $31.24B | — |
Dividend Yield | 1.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% amid a bearish technical signal, though it holds above key support at $218. The company reported strong Q4 2026 results with EPS of $2.95 beating estimates, and revenue grew 9% to a record $1.5 billion. However, weaker fiscal 2027 revenue guidance has pressured the stock. Fundamentals remain solid with a 26.94% net income margin and robust cash flow from operations of $1.75 billion in 2025.
The outlook is mixed; strong profitability and consistent earnings beats support upside toward the $235.70 consensus price target, but near-term sentiment is cautious due to the soft sales forecast and ongoing legal investigations. Key risks include competitive pressures and execution on guidance. Institutional buying by firms like HSBC and Canada Pension Plan provides confidence in long-term value.
USO is trading at $146.03, up 2.87% amid strong bullish momentum driven by escalating Middle East tensions pushing oil prices higher. The technical picture shows overwhelming bullish signals with moving averages strongly supporting upward momentum, though oscillators indicate potential overbought conditions. Recent news highlights supply disruptions in the Strait of Hormuz driving Brent crude above $100 per barrel, creating favorable conditions for energy sector performance.
The outlook remains positive as geopolitical tensions continue to support oil prices, though elevated RSI levels suggest near-term consolidation risk. Key resistance at $147-$150 presents the next challenge, while support at $144-$142 provides downside protection. Energy sector strength appears sustainable given ongoing supply constraints and OPEC+ production discipline.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
